(2) Failing this, meanwhile there should be:
(a) specified progressive restriction of the sums the tobacco industry is permitted to spend on sponsorship;
(b) limitation of any agreement to a period of not more than two years; after which a fresh agreement should be negotiated; and (c) regular monitoring of how the agreement is implemented in practice. (3) In addition, any advertisements at and for events where sponsorship by tobacco interests is permitted to continue for the present should carry a Government health warning, in similar terms to those on standard cigarette advertisements.
We do understand the temptation to accept, for the laudable objective of promoting sport, the large sums of money which can be obtained from tobacco companies through sponsorship. But, as a member of the Government, we feel sure you will recognise your wider responsibility for the welfare of the public.
As the public clearly has a major interest in any agreement on tobacco sports sponsorship which may be made on their behalf, we believe that they are entitled to be made fully aware of the concern of members of the medical profession. We are therefore sending copies of this letter to Members of Parliament and to the press as well as to the Secretaries of State for Health and Social Security, for England and Wales, for Scotland, and for Northern Ireland.
We would welcome the opportunity for a delegation of the signatories to meet to to discuss these issues. taking any effective action in this matter, which has become increasingly political over the last 10 years ? For two days last week 15 people from 10 countries ("the top flight of European antismokers," as Sir John Crofton described them) sat round a table in Edinburgh and tried to answer these two questions. Ostensibly they were concerned only with the first question, but several participants wondered whether the WHO, with its need to try and "please all the member states all the time," could achieve anything.
The WHO itself already has a smoking policy (see box)' which is in effect to shrink progressively the tobacco market until it disappears. But until now both in the main headquarters in Geneva and in the regional headquarters in Copenhagen smoking has not been seen by the WHO as one of its priorities. A few conferences and workshops have been held, data (much of them of doubtful value) have been gathered, reports and recommendations have been produced, and laboratory services about smoking. They reported back to the whole group with about 50 ideas, which were then distilled into a programme. Thirteen themes were identified and lines of action were recommended-some to be begun in 1982-3 and some to fit into the next WHO session, which lasts from 1984 to 1989. To come to pass these recommendations do, of course, have to be accepted by the WHO authorities. Theme 1: promoting smoking control in countries where there is little activity-Most of the participants thought that WHO Europe could achieve most with this kind of activity. The main areas needing help are Eastern Europe, southern Europe, and the German-speaking countries. The plan is to hold training and information workshops on smoking control in these countries. These will be followed by visits by smoking-control experts to the various countries; they will attempt to "get things going."
Theme 2: producing data on smoking rates in all European countriesThis project will be in two parts: one part will be to collect good data and the second to produce mathematical and economic models predicting how consumption and mortality will change. Trying to collect data by sending questionnaires to governments is useless: instead, governments will be asked to organise in their countries a predesigned study. The Finns will then use these and other data to produce the models; in the words of Dr Matti Rimpela from Finland, "Governments will then be able to decide how many people they want to die from lung cancer."
Theme 3: special groups-The meeting was concerned that something should be done for women, children, and people at work and suggested that studies should be commissioned on smoking and women, smoking and pregnancy, and smoking and work. There will be a large international conference on women and health in 1983 and information should be presented there on women and smoking. Information gathered on smoking and work will be presented to international unions, and WHO Europe will hope to work with them. Ideas were less clear on what should be done to combat smoking in children in Europe. One essential is to gather data, and another plan is to work with UNICEF.
Theme 4: an expert report on smoking in Europe-Reports on the "state of the art" should be published every few years; they can be very useful when dealing with uninterested governments.
Theme 5: producing information on "upper limits" and "product modification"-Both scientific and political thinking on setting upper limits on the tar, nicotine, and carbon monoxide content of cigarettes and on ways of modifying the content of cigarettes is confused, and the conference thought that a clear scientific document on this issue would be invaluable. This could be difficult for WHO to produce, and it was felt that a report could be produced more quickly by a nongovernmental agency such as the International Union Against Cancer.
Theme 6: passive smoking-Passive smoking is one of the issues that most upsets tobacco companies. The conference suggested that a large conference on the issue should be organised, that WHO Europe should push for more no-smoking zones, and that "a declaration of the rights of the non-smoker" should be produced. Any blaming of smokers, must, however, be avoided. The letter might also be sent to the media so that the governments would be encouraged to answer. Recommendations were also made that WHO Europe should contact all non-governmental organisations concerned with smoking.
Theme 8: visible promotion-Changing the smoking behaviour of populations inevitably means lots of publicity about antismoking activities, and also inevitably the WHO is concerned to be seen to be doing something. Slogans are important in this respect, and several were discussed. Another antismoking day was suggested, and Mike Daube from Edinburgh, always an ambitious thinker, suggested an antismoking decade to start in 1990.
Theme 9: studying and stigmatising the tobacco industry-The participants thought that as they sat in Edinburgh discussing ways of reducing smoking another group from the tobacco industry was probably sitting in another European city thinking how to increase tobacco consumption and "neutralise" the antismoking activities of WHO. The tobacco industry studies antismoking activities avidly, and the participants thought that WHO Europe should study the strategies of the tobacco industry in Europe. It should also make great play of the harm that the tobacco industry is doing.
Theme 10: price policy on cigarettes in Europe-In the last analysis putting up the price of tobacco is probably the most effective way of reducing smoking problems, and the group thought that a WHO study on this topic would be important in influencing governments. Actinomycetes have been found in about one-third of smears from patients wearing IUCDs: it has been suggested' that intrauterine devices affect only Actinomyces israelii and not other species. According to a British report,2 actinomyces-like organisms were found in almost one-third of smears from women using plastic IUCDs, but in only 1-2% of smears from women using copper-containing devices. The presence of the organisms was highly significantly correlated2 with pain and clinical evidence of genital infection. These findings suggest that an asymptomatic woman with a copper IUCD should probably have cervical smears no oftener than a patient using any other form of contraception. As to cervical dysplasia, a report3 from India gives a 2 3% incidence of dysplastic lesions among users of various copper IUCDs (compared with a 477% incidence among women using the loop), and a four-year follow-up of 461 women using copper-containing IUCDs failed to show a higher incidence of dysplasia than with plastic ones. A report4 from another centre on 815 women using copper devices found that 3 7% had dysplastic lesions when the device was inserted and 5 3% at 36-month follow-up, but all the patients subsequently had normal smears at 48-month follow-up. These results are reassuring, particularly since there is no theoretical reason4 to expect the copper to have harmful effects on the cervical epithelium.-j 0 DRIFE, lecturer in obstetrics and gynaecology, Bristol. 
